Abingworth closes record life sciences fund at £300 million

Abingworth has closed a record £300 million fund, which will target life sciences investments in Europe and North America.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this